X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (17) 17
humans (13) 13
male (7) 7
oncology (7) 7
female (6) 6
middle aged (6) 6
aged (5) 5
animals (5) 5
cancer (5) 5
analysis (4) 4
article (4) 4
chemotherapy (4) 4
expression (4) 4
lymphoma, b-cell - genetics (4) 4
pharmacology & pharmacy (4) 4
adult (3) 3
antibodies, monoclonal - administration & dosage (3) 3
antibodies, monoclonal - therapeutic use (3) 3
antineoplastic agents - therapeutic use (3) 3
apoptosis (3) 3
chronic lymphocytic-leukemia (3) 3
health care sciences & services (3) 3
hiv-1 (3) 3
lymphoma, b-cell - pathology (3) 3
lymphomas (3) 3
monoclonal antibodies (3) 3
recurrence (3) 3
research (3) 3
risk factors (3) 3
treatment outcome (3) 3
usage (3) 3
veterans (3) 3
abridged index medicus (2) 2
activation (2) 2
anti-cd20 monoclonal-antibody (2) 2
antibodies, monoclonal - adverse effects (2) 2
antineoplastic agents - administration & dosage (2) 2
antineoplastic agents - adverse effects (2) 2
asthma (2) 2
b-cell lymphoma (2) 2
biochemistry (2) 2
biochemistry & molecular biology (2) 2
biophysics (2) 2
blood (2) 2
cell biology (2) 2
cell line, tumor (2) 2
combined modality therapy (2) 2
complications and side effects (2) 2
computer applications to medicine. medical informatics (2) 2
cos cells (2) 2
dna polymerases (2) 2
dosage and administration (2) 2
drug therapy (2) 2
drugs (2) 2
empirical research (2) 2
follicular lymphoma (2) 2
follow-up (2) 2
fusion proteins, gag-pol - metabolism (2) 2
gag polyprotein (2) 2
gene expression (2) 2
gene mutations (2) 2
gene products, gag - metabolism (2) 2
health aspects (2) 2
health policy & services (2) 2
hematology (2) 2
hemic and lymphatic diseases (2) 2
hiv-1 - genetics (2) 2
hiv-1 - metabolism (2) 2
immunology (2) 2
immunology and allergy (2) 2
in-vivo (2) 2
inflammation (2) 2
infusions, intravenous (2) 2
japan (2) 2
leukemia (2) 2
life sciences (2) 2
lymphocytes (2) 2
lymphoma (2) 2
lymphoma, b-cell - drug therapy (2) 2
lymphoma, t-cell, cutaneous - drug therapy (2) 2
management (2) 2
medical research (2) 2
medicine, general & internal (2) 2
mice (2) 2
mycosis fungoides - drug therapy (2) 2
mycosis fungoides - pathology (2) 2
packaging (2) 2
plasma-membrane (2) 2
programmed cell death 1 ligand 2 protein - metabolism (2) 2
programmed cell death 1 receptor - antagonists & inhibitors (2) 2
proteases (2) 2
quality (2) 2
response criteria (2) 2
reverse transcriptase (2) 2
ribonuclease (2) 2
skin neoplasms - drug therapy (2) 2
stat3 (2) 2
t-cell lymphoma (2) 2
t-cells (2) 2
therapy (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 5300 - 5300
Introduction: MAVORIC was an open-label, multicenter, randomized phase 3 study evaluating the safety and efficacy of mogamulizumab (moga) compared to... 
Journal Article
Clinical Lymphoma Myeloma and Leukemia, ISSN 2152-2650, 09/2017, Volume 17, pp. S363 - S364
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 104 - 104
Abstract Introduction DLBCL is the most common lymphoid neoplasm in adults (Swerdlow 2016). While durable CRs are achieved in approximately 70% of patients... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 637 - 637
Abstract Background: Patients (pts) with CLL who relapse after or become refractory to B-cell receptor inhibitor (BCRi) therapy experience poor outcomes. VEN... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 3502 - 3502
Abstract Introduction: Allo-HSCT is a potentially curative option for patients (pts) with classical Hodgkin lymphoma (cHL) who relapse after autologous... 
Journal Article
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 1745 - 1745
Abstract Background Outcomes for patients with DLBCL have improved over the past decade, with the addition of rituximab to CHOP or CHOP-like multi-agent... 
Journal Article
Journal of Virology, ISSN 0022-538X, 04/2002, Volume 76, Issue 8, pp. 4131 - 4137
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 814 - 814
Abstract Introduction RCHOP is the standard frontline treatment for patients with DLBCL. However, for patients with high-intermediate or high-risk disease (IPI... 
Journal Article
Pharmacoepidemiology and Drug Safety, ISSN 1053-8569, 01/2015, Volume 24, Issue 1, pp. 86 - 92
Journal Article
Journal of the National Comprehensive Cancer Network : JNCCN, 02/2018, Volume 16, Issue 2, p. 123
Natural killer (NK)/T-cell lymphomas are a rare and distinct subtype of non-Hodgkin's lymphomas. NK/T-cell lymphomas are predominantly extranodal and most of... 
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 291 - 291
Abstract Introduction Programmed cell death-1 (PD-1) is an immune checkpoint receptor that inhibits T cell activation upon interaction with its ligands PD-L1... 
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 289 - 289
Abstract Introduction: Classical Hodgkin lymphoma (cHL) is characterized by Reed Sternberg (RS) cells surrounded by an extensive but ineffective... 
Journal Article
EGEMS (Washington, DC), ISSN 2327-9214, 07/2019, Volume 7, Issue 1, p. 23
The goal of this study was to compare the performance of several database algorithms designed to identify red blood cell (RBC) Transfusion Related hospital... 
Journal Article
Biochimica et Biophysica Acta - Gene Regulatory Mechanisms, ISSN 1874-9399, 03/2016, Volume 1859, Issue 3, pp. 436 - 443
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.